Mediolanum International Funds Ltd increased its stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) by 143.7% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 46,622 shares of the financial services provider’s stock after buying an additional 27,492 shares during the quarter. Mediolanum International Funds Ltd’s holdings in Marsh & McLennan Companies were worth $8,146,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in MRSH. State Street Corp bought a new position in shares of Marsh & McLennan Companies during the 4th quarter valued at approximately $4,057,682,000. Capital International Investors bought a new stake in shares of Marsh & McLennan Companies in the 4th quarter worth approximately $3,482,557,000. Capital World Investors purchased a new position in Marsh & McLennan Companies in the fourth quarter valued at approximately $3,140,284,000. Wellington Management Group LLP bought a new position in Marsh & McLennan Companies during the fourth quarter valued at $2,967,927,000. Finally, Price T Rowe Associates Inc. MD purchased a new stake in Marsh & McLennan Companies in the fourth quarter worth $1,710,101,000. 87.99% of the stock is currently owned by hedge funds and other institutional investors.
Marsh & McLennan Companies Stock Down 0.2%
MRSH stock opened at $181.82 on Tuesday. Marsh & McLennan Companies, Inc. has a twelve month low of $156.60 and a twelve month high of $213.80. The stock has a market cap of $87.84 billion, a price-to-earnings ratio of 22.73, a P/E/G ratio of 2.74 and a beta of 0.61. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28.
Marsh & McLennan Companies Increases Dividend
Insiders Place Their Bets
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the sale, the chief executive officer directly owned 116,811 shares in the company, valued at $18,889,506.81. This represents a 12.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.38% of the company’s stock.
Wall Street Analysts Forecast Growth
MRSH has been the topic of several research reports. UBS Group boosted their target price on Marsh & McLennan Companies from $203.00 to $212.00 and gave the company a “buy” rating in a research note on Wednesday, July 8th. JPMorgan Chase & Co. lifted their price objective on Marsh & McLennan Companies from $206.00 to $212.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Piper Sandler lowered their price objective on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 26th. Morgan Stanley cut their target price on shares of Marsh & McLennan Companies from $180.00 to $175.00 and set an “equal weight” rating for the company in a research report on Monday, July 6th. Finally, Cantor Fitzgerald lifted their target price on shares of Marsh & McLennan Companies from $210.00 to $218.00 and gave the stock an “overweight” rating in a research note on Thursday, July 9th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $200.81.
Get Our Latest Stock Analysis on Marsh & McLennan Companies
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
See Also
- Five stocks we like better than Marsh & McLennan Companies
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
